Woo Keon | Public Health | Best Researcher Award

Mr. Woo Keon | Public Health | Best Researcher Award

Mr. Woo Keon, Graduate School of Transdisciplinary Health Science, Yonsei University, South Korea

Mr. Keon Woo is a dedicated graduate student at Yonsei University’s Graduate School of Transdisciplinary Health Sciences, specializing in the Department of Biohealth Industry. With a strong academic foundation from Eulji University in Healthcare Management, Keon’s focus lies in integrating smart healthcare information with social and policy dimensions of health. Passionate about addressing health disparities, Keon actively engages in research that bridges healthcare management and health sociology, aiming to improve service quality and accessibility. His interdisciplinary approach highlights the social determinants impacting health outcomes, with a commitment to advancing equitable healthcare systems through data-driven insights and policy evaluation.

👤 Profile

Orcid

🎓 Education

Mr. Keon Woo completed his Bachelor’s degree in Healthcare Management, majoring in Smart Healthcare Information at Eulji University (2019–2025), South Korea. He is currently pursuing graduate studies at Yonsei University’s Graduate School of Transdisciplinary Health Sciences in the Department of Biohealth Industry (2025–present). This academic path reflects Keon’s commitment to blending technology and health policy to better understand healthcare systems and optimize healthcare delivery. His education equips him with a unique perspective combining management, sociology, and technological innovation in healthcare, enabling him to tackle complex challenges in health disparities and service quality.

💼 Experience

Mr. Keon Woo’s research experience includes presenting his work on outpatient experience’s effect on hospital recommendation willingness at the Korean Society of Hospital Management Fall Conference in 2024. This oral presentation demonstrated his ability to conduct applied research with real-world healthcare implications. Recently, he authored a significant paper investigating the link between obstructive sleep apnea and oral function using national health survey data, shedding light on disparities affecting socioeconomically disadvantaged populations. Additionally, Keon participates in ongoing projects analyzing variations in healthcare utilization and costs among older adults, emphasizing socioeconomic and demographic stratifications, thereby contributing valuable insights to healthcare management and policy.

🔬 Research Interests

Mr. Keon’s main research interests focus on Health Sociology, Health Policy, Healthcare Management, and the Social Determinants of Health. He is passionate about understanding how social and economic factors influence healthcare access and outcomes, particularly for vulnerable populations. His work integrates interdisciplinary methodologies to analyze healthcare disparities, quality of services, and cost burdens. By exploring these dimensions, Keon aims to support policy formulation and healthcare management practices that reduce inequities and enhance patient-centered care, especially in aging populations and underserved communities.

🏆 Awards

While formal awards for Keon Woo are not listed, his selection to present at the 2024 Fall Conference of the Korean Society of Hospital Management is a testament to his research excellence and growing recognition in the healthcare management community. This opportunity reflects his dedication and potential as an emerging researcher focused on impactful health services research.

📚 Publication

 “The Association Between Obstructive Sleep Apnea and Oral Function” was published in Healthcare (MDPI) in 2025.

Xiaosong Gu | Food and health | Best Researcher Award

Assist Prof Dr. Xiaosong Gu – Food and health  – Best Researcher Award

ANGEL YEAST CO., LTD | China

      Profiles

Scopus

📍Current Position

Dr. Xiaosong Gu currently serves as a key researcher at Angel Yeast Co., TD, Yichang Hubei PRC, China (2023-present). His current focus is on advancing yeast metabolism and synthetic biology—two critical areas within industrial biotechnology. He is committed to driving innovation through the development and application of efficient gene-editing methods for industrial yeast, which hold great potential for improving bio-manufacturing processes. Dr. Gu’s expertise in synthetic biology and metabolism allows him to explore cutting-edge biotechnology solutions in industrial applications.

 

📝Publication Achievements 

Dr. Gu’s research excellence is reflected in his numerous publications, particularly in areas such as microalgae oil metabolism, yeast metabolism, and synthetic biology. His innovative work on galactolipid remodeling at the chloroplast membrane in response to abiotic stress in algae has earned him recognition in prestigious journals. Moreover, his groundbreaking findings on antibody modifications have led to significant advancements in biotechnology. Dr. Gu’s work extends to patents, including:

Strain expressing genetic engineering of single antibody against Citreoviridin (Application number CN201610325110).

A method for the preparation of genetically engineered IgG antibodies in Escherichia coli (Publication number CN106244612A).

 

🔍Ongoing Research

Dr. Gu’s ongoing research projects include exploring the regulation of abiotic stress responses in photosynthetic algae, with a special focus on algae biofuels and solar energy conversion. By utilizing algae as a model system, particularly Chlamydomonas reinhardtii, he is investigating ways to enhance biomass productivity and boost primary and secondary metabolism. His goal is to revolutionize the sustainable production of biofuels and improve the efficiency of solar energy harnessed by green algae.

 

🔬 Research Interests

Yeast Metabolism and Synthetic Biology: Dr. Gu is passionate about understanding and manipulating yeast metabolic pathways to improve industrial processes. Microalgae Biofuels: He has a strong interest in leveraging algae for sustainable fuel production and enhancing solar energy conversion efficiency. Phage Display and DNA Aptamer Screening Technology: Dr. Gu is skilled in using these technologies to facilitate protein-protein and nucleic acid-protein interactions, leading to the rapid detection of toxins and pathogens.

 

🎓Academic Background

Ph.D. in Biology from the Institute of Hydrobiology, Chinese Academy of Sciences (2020), specializing in microalgae oil metabolism. Post-doctoral Research in synthetic biology from ZJU-Hangzhou Global Scientific and Technological Innovation Center (2021-2023), focusing on yeast metabolism. MSc in Biology from Fujian Agriculture and Forestry University (2016), specializing in small molecule antibody modification. BSc in Biology from Chuxiong Normal University (2013), with a focus on fermentation engineering.

 

🏆Scholarships and Awards 

National Encouragement Scholarship, China (2011). Excellent Graduate of Yunnan Province (2013). Merit Student Award, Chinese Academy of Sciences (2019).

 

🧬Bioinformatics 

Dr. Gu has gained considerable expertise in bioinformatics, using computational tools to analyze and interpret biological data. His knowledge of bioinformatics is critical for understanding complex biological systems, particularly in synthetic biology and metabolic engineering.

 

🌐Professional Associations 

Dr. Gu is an active member of several professional associations in the fields of biotechnology, algae research, and synthetic biology. His collaborations with fellow researchers have enabled cross-disciplinary innovation, particularly in algal biotechnology and industrial yeast research.

 

 📚Training & Workshops 

Dr. Gu has participated in numerous workshops and training programs, honing his skills in advanced biotechnology, antibody preparation, and gene editing. These experiences have equipped him with cutting-edge techniques essential for modern biological research.

 

🎤Oral Presentations and🗣️Thought Leadership 

19th Symposium of Algae Branch of Marine Limnology Society of China (2017): Presented his research on galactolipid remodeling in algae.

1st Sino-British Forum on Algal Biotechnology and Biological Resources (2019): Delivered a presentation on triacylglycerol biosynthesis in Chlamydomonas reinhardtii.

 

🧑‍🔬Tasks Completed as a Researcher 

Development of genetically engineered antibodies for rapid toxin detection. Implementation of phage display technologies for protein interaction studies. Advancing algae biofuel technologies through metabolic engineering.

 

🚀Success Factors 

His ability to integrate synthetic biology with biotechnology to address pressing global challenges. Innovation in gene editing techniques for industrial applications. A collaborative mindset that fosters interdisciplinary research.

 

🧪Publications & Laboratory Experience

Dr. Gu’s extensive experience in laboratory work has allowed him to contribute to several publications. His expertise ranges from the development of monoclonal and single-chain antibodies to the application of colloidal gold rapid detection kits for small molecule toxins. He has also spearheaded projects involving gene-editing in yeast and lipid remodeling in algae.

 

🔍 Conclusion

Dr. Xiaosong Gu is a forward-thinking researcher whose contributions span multiple areas of biotechnology, from algae biofuels to antibody technology. His innovative approach and dedication to sustainable solutions make him a rising star in the field of synthetic biology and industrial biotechnology. With his impressive academic background, groundbreaking research, and numerous accolades, Dr. Gu is poised to continue making significant impacts in food, health, and energy industries.

📚Publications

 

Establishment of Saccharomyces cerevisiae as a cell factory for efficient de novo production of monogalactosyldiacylglycerol

         Authors: Gu, X., Shi, Y., Luo, C., Cheng, J.

         Journal: Biotechnology for Biofuels and Bioproducts,

Biomanufacturing of γ-linolenic acid-enriched galactosyldiacylglycerols: Challenges in microalgae and potential in oleaginous yeasts

         Authors: Gu, X., Huang, L., Lian, J.

         Journal: Synthetic and Systems Biotechnology,